Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00738751
Recruitment Status : Completed
First Posted : August 20, 2008
Last Update Posted : February 4, 2015
Genentech, Inc.
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2013
  Actual Study Completion Date : February 2015